Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 11,636,400 | 10,560,150 | 9,196,428 | 11,285,860 | 13,217,500 |
| Cost of Goods | 3,265,670 | 2,953,910 | 2,472,070 | 3,047,850 | 3,441,760 |
| Gross Profit | 8,110,309 | 7,604,860 | 8,008,510 | 8,439,360 | 9,706,242 |
| Operating Expenses | 8,641,480 | 4,571,260 | 7,932,490 | 5,170,641 | 5,696,561 |
| Operating Income | -270,078 | 3,035,891 | -1,208,063 | 3,068,220 | 4,079,939 |
| Other Income | -506,702 | -247,801 | 1,063,353 | -53,160 | -451,889 |
| Pre-tax Income | -776,780 | 2,788,090 | -144,710 | 3,015,060 | 3,628,050 |
| Income Tax | 241,520 | 706,700 | 231,240 | 836,910 | 944,540 |
| Net Income Continuous | -1,115,620 | 2,081,650 | -427,000 | 2,055,600 | 2,723,844 |
| Net Income | $-1,115,620 | $2,081,650 | $-427,000 | $2,055,600 | $2,723,844 |
| EPS Basic Total Ops | -0.55 | 0.98 | -0.23 | 1.01 | 1.30 |
| EPS Basic Continuous Ops | -0.55 | 0.98 | -0.23 | 1.01 | 1.30 |
| EPS Diluted Total Ops | -0.54 | 0.98 | -0.23 | 1.00 | 1.30 |
| EPS Diluted Continuous Ops | -0.54 | 0.98 | -0.23 | 1.00 | 1.30 |
| EBITDA(a) | $616,902 | $3,966,811 | $-551,193 | $3,795,830 | $4,021,479 |